AzTrials
AzTrials

Muscle StrainNCT02152098

Skeletal Muscle Strain Injuries and the Connective Tissue: Characterization, Recovery and Optimal Treatment

A study testing Acute Early onset of rehabilitation, Acute Delayed onset of rehabilitation and Chronic Exercise in people with Muscle Strain, run by Bispebjerg Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Firstly, the investigators aim to study the biochemical, structural and functional changes associated with acute muscle strain injury in the acute phase and during rehabilitation in vivo. Specific factors present after the injury and their effects on connective tissue cells will be examined in vitro. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Muscle Strain
What is being tested?
Acute Early onset of rehabilitation, Acute Delayed onset of rehabilitation and Chronic Exercise
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
85 participants
Where
1 siteDenmark
Study dates
Apr 2014to Mar 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Acute muscle strain injury
  • Chronic muscle strain injury
  • Age above 18 years

Who cannot join

  • Daily intake of non-steroidal anti-inflammatory drugs (NSAIDs) within three months prior to the injury
  • Smoking
  • Diabetes
  • Connective tissue and/or rheumatic diseases
  • Any observed organ dysfunctions

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Institute of Sports Medicine Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, Building 8

    Copenhagen, 2400

Other trials in Denmark

About this study

Firstly, the investigators aim to study the biochemical, structural and functional changes associated with acute muscle strain injury in the acute phase and during rehabilitation in vivo. Specific factors present after the injury and their effects on connective tissue cells will be examined in vitro.

Secondly, the investigators will investigate individuals with chronic pain, scar tissue and inferior function after a previous muscle strain injury and test a specific rehabilitation program to alleviate pain and disabilities associated with the preceding muscle injury. The investigators have the following hypotheses:

  1. Humoral growth factors and pro-inflammatory macrophages released into the injured area post strain injury stimulate formation of connective tissue in vitro.
  2. Early onset of rehabilitation will be superior to a delayed start of rehabilitation for the healing process, in regards to structural improvement of tissue and better clinical function.
  3. Scar tissue following a muscle strain injury is characterized by disorganized structure of connective tissue.
  4. Mechanical loading in the form of heavy eccentric muscle activity for 12 weeks will lead to a local re-modeling of scar tissue, and result in improved function and reduced symptoms in patients with chronic pain and impaired function after a previous muscle injury.
Conditions
Muscle Strain
Being tested
Acute Early onset of rehabilitation, Acute Delayed onset of rehabilitation, Chronic Exercise, Chronic Control
Medical subject headings
Sprains and Strains

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acute Early onset of rehabilitationProcedure or surgery

    Early onset of rehabilitation

  • Acute Delayed onset of rehabilitationProcedure or surgery

    Delayed onset of rehabilitation

  • Chronic ExerciseProcedure or surgery

    Exercise

  • Chronic ControlProcedure or surgery

    Control

Study groups in NCT02152098
Study groupRoleWhat they receive
Chronic ExerciseExperimentalChronic Exercise
Receives: Procedure: Chronic Exercise
Acute Early onset of rehabilitationExperimentalAcute Early onset of rehabilitation
Receives: Procedure: Acute Early onset of rehabilitation
Chronic controlExperimentalChronic control
Receives: Procedure: Chronic Control
Acute Delayed onset of rehabilitationExperimentalAcute Delayed onset of rehabilitation
Receives: Procedure: Acute Delayed onset of rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Return to full physical activity

    First time the subject is fully fit to take part in all types of physical activity post injury;

    Measured: Baseline; Up to 30 weeks (estimated time frame maximum)

Secondary outcomes (6)
  1. Magnetic resonance images

    Size of injured tissue; Size and location of hematoma; Measurement of muscle perfusion (indication of metabolic activity)

    Measured: Baseline, 4 weeks, 6 weeks, 12 weeks, 6 months

  2. Ultrasound images

    Size and location of injury

    Measured: Baseline, 7-14 days, 4 weeks, 6 weeks, 12 weeks, 6 months

  3. Ultrasound images

    Volume of hematoma

    Measured: Baseline, 1 week, 2 weeks

  4. Strength measurements

    Strength tests of injured muscle group compared to healthy muscle group on contralateral leg

    Measured: Baseline, 4 weeks, 6 weeks, 9 weeks, 12 weeks, 6 months

  5. Structural changes of tissue

    Evaluation of tissue samples from injured muscle before and after rehabilitation program

    Measured: Baseline, 12 weeks

  6. Aspiration and characterization of inter-/ intramuscular fluid in the injured muscle

    The aspirated fluid (hematoma/exudate) will be analyzed for released humoral factors, cell types present and its effect on human fibroblast proliferation

    Measured: Baseline, 3 -14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionDec 2016
  4. Study completionMar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
85 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02152098
Sponsor's protocol ID
MI-114
Status last verified
Jul 2017
First submitted
23 May 2014
Last updated
26 Jul 2017
Results posted
No
Data monitoring committee
No

Publications

  • Bayer ML, Hoegberget-Kalisz M, Svensson RB, Hjortshoej MH, Olesen JL, Nybing JD, Boesen M, Magnusson SP, Kjaer M. Chronic Sequelae After Muscle Strain Injuries: Influence of Heavy Resistance Training on Functional and Structural Characteristics in a Randomized Controlled Trial. Am J Sports Med. 2021 Aug;49(10):2783-2794. doi: 10.1177/03635465211026623. Epub 2021 Jul 15.

    PubMed 34264782

Questions about this trial

What is this clinical trial studying?

A study testing Acute Early onset of rehabilitation, Acute Delayed onset of rehabilitation and Chronic Exercise in people with Muscle Strain, run by Bispebjerg Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Return to full physical activity (time frame: Baseline; Up to 30 weeks (estimated time frame maximum)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02152098, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in